Lower risk Drug recall · FDA · Published May 26, 2021

McKesson Drug Company Recalls Levetiracetam Tablets Due to Barcode Error

McKesson Drug Company recalls Levetiracetam 250mg tablets due to a barcode error that could cause misidentification with Naproxen 500mg tablets. The product is labeled correctly as Levetiracetam but may be scanned incorrectly.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0630-2021Drug McKesson Drug Company ›

Lower-risk recall

Labeling; Wrong Barcode; error in the machine-readable barcode which could result in some units being read as Naproxen Tablets 500 mg. Product is labeled correctly as Levetiracetam

Take action

Contact the company

Recalling firmMcKesson Corporation dba McKesson Drug Company4853 Crumpler Rd · Memphis, TN 38141-8301

✎ GovInfoNow plain-language explainer

McKesson Drug Company is recalling Levetiracetam 250mg tablets because of a barcode error that might cause some units to be scanned as Naproxen 500mg tablets. This could lead to confusion about which medication is being taken, though the product itself is labeled correctly. Read more at govinfonow.com/recall/36129-mckesson-drug-company-recalls-levetiracetam-tablets-due-to-barcode-error.

Source Summary by GovInfoNow · govinfonow.com/recall/36129-mckesson-drug-company-recalls-levetiracetam-tablets-due-to-barcode-error · Updated August 18, 2026 · FDA enforcement record: FDA #D-0630-2021

Cite this page

“McKesson Drug Company Recalls Levetiracetam Tablets Due to Barcode Error.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/36129-mckesson-drug-company-recalls-levetiracetam-tablets-due-to-barcode-error. Based on FDA recall #D-0630-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0630-2021%22&limit=1).

The FDA announced on May 26, 2021, that McKesson Corporation is recalling Levetiracetam Tablets USP, 250 mg due to a labeling error involving the machine-readable barcode. This defect could cause some units to be read as Naproxen Tablets 500 mg.

How to tell if you have it

Brand: McKesson Drug Company
Product: Levetiracetam Tablets USP, 250 mg UD 100 Tablets (10x10) boxes
NDC: 63739-795-10
Lot: 0000124916
Expiration Date: 09/30/2022
Quantity: 210 cartons
Distribution: Nationwide in the US

The hazard

The product has an error in the machine-readable barcode that could result in some units being read as Naproxen Tablets 500 mg. The product is labeled correctly as Levetiracetam.

Context

GovInfoNow's records show McKesson Corporation dba McKesson Drug Company has 1 other recall on record since 2022-04-21, specifically a 2022-04-21 recall of Lidocaine Topical Solution due to CGMP Deviations. Other recent recalls of similar products include American Regent Levocarnitine Injection Recall: Missing Label Hazard (2026-04-16), Unichem Recalls Doxazosin 4mg Tablets Due to Wrong ID Imprint (2026-01-21), and Eugia recalls Lidocaine injection due to label scanning issues (2026-05-18).

How to tell if you have this one

Check for Levetiracetam Tablets USP 250 mg UD 100 Tablets (10x10) boxes with NDC 63739-795-10 and lot number 0000124916. The product was distributed by McKesson Corporation in Memphis, TN.

Brand
McKesson Drug Company
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Product Label
Look for the NDC code 63739-795-10 and lot number 0000124916 on the box.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Nationwide in the US” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 16 months after the firm started it.

May 26, 2021Firm started the recall
Jun 15, 2021FDA classified it Class III
Jun 16, 2021Published in FDA’s Enforcement Report
Sep 29, 2022FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/36129-mckesson-drug-company-recalls-levetiracetam-tablets-due-to-barcode-error">McKesson Drug Company Recalls Levetiracetam Tablets Due to Barcode Error (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0630-2021 (May 26, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0630-2021 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.